• GW Malignant Hematology Program
  • Comprehensive Cancer Care

  • The GW Cancer Center Malignant Hematology program  specializes in the diagnosis and treatment of various blood cancers and autoimmune disorders. For more information call (202) 741-2210. 

Meet Our Team

Kieron Dunleavy, M.D.
Professor of Medicine, Director of the Lymphoma Program, Co-Director of the Microbial Oncology Program
Specialty: Cancer & Blood Disorders
Interests: Aggressive and indolent lymphomas, Viral/microbial associated lymphoid diseases
Faysal Haroun
Assistant Professor of Medicine
Specialty: Cancer & Blood Disorders, Medicine
Interests: Lung cancer, Benign and malignant blood disorders
Robert Siegel, M.D.
Professor of Medicine
Specialty: Cancer & Blood Disorders
Interests: Breast Cancer, Head and Neck Cancer
Mitchell Smith, M.D.
Division Director, Cancer & Blood Disorders, Professor of Medicine
Specialty: Cancer & Blood Disorders
Eduardo Sotomayor, M.D.
Professor of Medicine, Director, GW Cancer Center
Specialty: Cancer & Blood Disorders
Interests: mantle cell lymphoma
Imad Tabbara, M.D.
Professor of Medicine, Director, Blood & Bone Marrow Transplant Program, Director, Fellowship Training Program
Specialty: Thoracic Cancer Care Program, Cancer & Blood Disorders
Interests: Hematologic malignancies, Lung Cancer, Breast Cancer

Clinical Trials

Title Description
A Global, Prospective, Non-Interventional, Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Patients-the INSIGHT-MM study

The objective of this study is to describe contemporary, real-world patterns of patient characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in patients with newly diagnosed multiple myeloma and patients with relapsed/refractory multiple myeloma.
A Global, Prospective, Non-Interventional, Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Patients-the INSIGHT-MM study

The objective of this study is to describe contemporary, real-world patterns of patient characteristics, clinical disease presentation, therapeutic regimen chosen, and clinical outcomes in patients with newly diagnosed multiple myeloma and patients with relapsed/refractory multiple myeloma.

Info for Patients

GWCC Malignant Hematology Program
22nd & I Street, NW First Floor
Washington , DC
United States

Schedule an Appointment

202-741-2210